Vesper Bio ApS
32879861ActiveA clinical-stage biotech company developing oral therapies for neurodegeneration.
Clinical-stage biotechnology companyvesperbio.com
Översikt
- 7
- Anställda
- Okänt
- Omsättning
- 2010
- Grundat
Nyckelbeslutsfattare
Anders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
Andy Mulvaney
Business Development Consultant
John King-Underwood
Medicinal Chemistry Consultant
+1 fler kontakter i Funnelfeedr
Beskrivning
Vesper Bio is a clinical-stage biotechnology company dedicated to pioneering research in Sortilin biology. The organization focuses on developing innovative oral therapies for patients suffering from devastating and fatal disorders, specifically targeting Frontotemporal Degeneration. Founded on deep...